The precursor to major merozoite surface antigens: structure and role in immunity.
about
The cellular and molecular basis for malaria parasite invasion of the human red blood cellLow level of sequence diversity at merozoite surface protein-1 locus of Plasmodium ovale curtisi and P. ovale wallikeri from Thai isolatesGenetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infectionAn EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparumA recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malariaReaction of antimalarial endoperoxides with specific parasite proteins.A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami.Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in KoreaPartial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locusNaturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro.Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.Malaria infection by sporozoite challenge induces high functional antibody titres against blood stage antigens after a DNA prime, poxvirus boost vaccination strategy in Rhesus macaques.Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite iNatural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malariaConstitutive activation and accelerated maturation of peripheral blood T cells in healthy adults in Burkina Faso compared to Germany: the case of malaria?A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates.Duffy Blood Group System and the malaria adaptation process in humansA liver-stage specific antigen of P. berghei identified by a monoclonal antibody.Proteins with molecular masses of 25 to 40 kilodaltons elicit optimal protective responses against Plasmodium chabaudi adami infection.Antibody recognition and isoelectrofocusing of antigens of the malaria parasite Plasmodium yoelii.Immunomagnetic purification to facilitate DNA diagnosis of Plasmodium falciparum.Structural diversity in the Plasmodium falciparum merozoite surface antigen 2.Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species.Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived.Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum.
P2860
Q21032502-BE2B288D-5AE8-4A9C-AA64-C3E2A97F16B9Q21133624-54CCAE91-A913-4C35-BA33-07E641EC2EA1Q24514949-C88CC620-5FCE-4F1D-A7E0-0007BA446ED1Q30043132-9E233194-ED66-4677-A3C1-9DC0C021D15DQ33599911-40AA2479-B9F8-49AB-BF7D-D363DC58C74BQ33711883-21326C75-210A-47BD-B5EC-93DA668A42DAQ33742070-F31B18E9-AC53-4005-B2A8-59C4DCAD783CQ33752297-1E88A583-14D8-449E-B69D-286F7B42AE7FQ33757165-EEC2F6DD-A535-44AB-BF73-8DEBEB994DB3Q33858336-7C344963-3B80-49F4-9660-03DABFDF60CFQ33866742-C14C5937-4DAE-495F-86CA-1685CF9CCEB8Q33998800-FD112692-B9B0-4540-8689-651C83200AB1Q34000050-A20C8C7E-51B2-45D8-AE56-F78CAB6DD3ACQ34003987-834AF119-5964-490F-A66C-E09A5E2272E0Q34154429-9A514CA5-0C4B-404D-8E53-9C550DB4DF77Q34334187-583719F8-3399-4AB4-A079-60364E81B66FQ34416487-B1BDDAC8-8FFC-4CC1-877E-EA01B69CF332Q34541366-C9A1DF12-6493-4443-8189-D3A1AEE4B34CQ34546246-984EFC42-29B8-4505-BD22-72F8A2B3CA37Q34615872-39F9F97C-F721-4F01-9E37-04FCFDA1413EQ35212980-6D0F58B1-C4BF-4FDF-9245-E4006E2A74B0Q35498349-AC0794AE-3A0E-4FC4-8AEC-3A50CA95F3F2Q35505807-099A594E-38D5-452A-AB76-5FB8770920FEQ35546112-7F34F5DC-B58A-4FCC-B9C9-1C02BFAAAC2AQ35958745-58002C28-E486-48A1-AF2D-23BC53DD5FF2Q36352078-9C1AC870-625C-4C74-82C0-48A75528B922Q36368017-6F504402-3378-4040-B141-D2E4E88EDC20Q36464343-F6299B0A-6141-4378-BC2C-DCC0F60530F2Q36668538-39057854-6D4F-459F-84E6-0D6286124A62Q36972426-5FB6A0E9-2744-4D86-B154-C011436496FFQ36988658-A4FA3959-77EA-45BD-8AEA-6C871A96CA5CQ37138312-2DCAD1FF-6B7E-47CF-9878-3230D6A44226Q37415473-283E98F0-281D-49D2-8A6B-0A29E98CD764Q37506803-8FC01F4A-479C-489E-993C-F79D4C580D37Q39860521-0C0E97A5-4C88-4E19-B175-5182147B64F2Q40150215-C673474E-0D14-4914-9E85-09FA6CAE46C3Q41851051-A878B35D-8A57-4584-A656-AA5BEAA22AA0
P2860
The precursor to major merozoite surface antigens: structure and role in immunity.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The precursor to major merozoite surface antigens: structure and role in immunity.
@en
The precursor to major merozoite surface antigens: structure and role in immunity.
@nl
type
label
The precursor to major merozoite surface antigens: structure and role in immunity.
@en
The precursor to major merozoite surface antigens: structure and role in immunity.
@nl
prefLabel
The precursor to major merozoite surface antigens: structure and role in immunity.
@en
The precursor to major merozoite surface antigens: structure and role in immunity.
@nl
P1433
P1476
The precursor to major merozoite surface antigens: structure and role in immunity.
@en
P2093
P577
1988-01-01T00:00:00Z